Gabapentin neurotoxicity in a chronic haemodialysis patient.
Bassilios
N
N
Launay-Vacher
V
V
Khoury
N
N
Rondeau
E
E
Deray
G
G
Sraer
J D
JD
D000085:Acetates / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D000328:Adult; D000588:Amines; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D003509:Cyclohexanecarboxylic Acids; D004827:Epilepsy / Q000097:blood / Q000150:complications / Q000188:drug therapy; D004832:Epilepsy, Absence / Q000209:etiology; D005260:Female; D000077206:Gabapentin; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000628:therapy; D009420:Nervous System / Q000187:drug effects*; D006435:Renal Dialysis / Q000009:adverse effects*; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin